Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03023449
PHASE2

Diffuse Optical Monitoring With Inhaled Nitric Oxide

Sponsor: Steven Messe

View on ClinicalTrials.gov

Summary

This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate, cardiac output, respiratory rate, end oxygen saturation, and inhaled nitric oxide (NO)/nitrogen dioxide (NO2) concentration, are continuously monitored.

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2017-04-04

Completion Date

2026-07

Last Updated

2025-08-24

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Nitric Oxide

Inhaled Nitric Oxide gas

Locations (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States